Intellia Therapeutics Inc (NAS:NTLA)
$ 23.96 0.24 (1.01%) Market Cap: 2.31 Bil Enterprise Value: 1.49 Bil PE Ratio: 0 PB Ratio: 2.12 GF Score: 63/100

Intellia Therapeutics Inc (NTLA) Stock Estimates Data

Intellia Therapeutics Inc (NTLA) 12 Month Price Targets

Intellia Therapeutics Inc (NTLA) Analyst Rating